Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity

Phytotherapy Research

Volumn 19, Issue 3, 2005, Pages 193-197

  Tasduq, S A ^a   Kaisar, P ^a   Gupta, D K ^a   Kapahi, B K ^a   Jyotsna, S ^b   Maheshwari, H S ^c   Johri, R K ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

^c DR H S GOUR UNIVERSITY   (India)

Author keywords

Anti TB drugs; Antioxidant; Emblica officinalis; Hepatotoxicity; Isoniazid; Pyrazinamide; Rifampicin

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CYTOCHROME P450 2E1; EMBLICA OFFICINALIS EXTRACT; GLUTATHIONE; ISONIAZID; LIVER PROTECTIVE AGENT; PLANT EXTRACT; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; EMBLICA OFFICINALIS; ENZYME INHIBITION; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CELL CULTURE; LIVER FUNCTION; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; RAT; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; FRUIT; HEPATITIS, TOXIC; HEPATOCYTES; HUMANS; ISONIAZID; MALE; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; PYRAZINAMIDE; RATS; RATS, WISTAR; RIFAMPIN; TUBERCULOSIS, PULMONARY;

PHYLLANTHUS EMBLICA;

EID: 20444504699     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1631     Document Type: Article

References (19)

1. Attri S, Rana SV, Vaiphei K, et al. 2000. Isoniazid and rifampicin induced oxidative hepatic injury-protection by N-acetyl cysteine. Human Exp Toxicol 19: 517-522.
2. Carrillo MC, Kanai S, Nokubo M, Kitani K. 1991. (-) Deprenyl induces activities of both superoxide dismutase and catalase but not glutathione peroxidase in the striatum of young male rats. Life Sci 48: 517-521.
3. Farombi EO, Akinloye O, Akinmoladun CO, Emerole GO. 1999. Hepatic drug metabolising enzyme induction and serum triglycerol elevation in rats treated with chlordiazepoxide, griseofulvin, rifampicin and phenytoin. Clin Chim Acta 289: 1-10.
4. Fladmark KE, Serres MH, Larsen NL, Yasumoto T, Aune T. 1998. Sensitive detection of apoptogenic toxins in suspension cultures of rat and salmon hepatocytes. Toxicon 36: 1101-1114.
5. Ghosal S, Bhattacharya A, Bhattacharya SK. 2003. Antioxidant effects of Emblica officinalis and their biological consequences. In Recent Progress in Medicinal Plants (vol. 8) Majumdar DK, Govil JN, Singh VK (eds). Studium Press: USA.
6. Halliwell B, Gutteridge JMC. 1989. Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity. In Free Radicals in Biology and Medicine, Halliwell B, Gutteridge JMC (eds), Oxford University Press: New York, 86-187.
7. Johnson TN, Tanner MS, Tucker GT. 2002. Developmental changes in the expression of enterocytic and hepatic cytochromes P450 1A in rat. Xenobiotica 32: 595-604.
8. Limaye PB, Udayan M, Kartik S, Bucci TJ, Warbriffan A, Mehendale HM. 2003. Culpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants Toxicol App Pharmacol 191: 211-226.
9. Linhardt K, Walter K. 1963. Phosphatases (phosphomonoesterases): determination in serum with p-nitrophenyl phosphate. In Methods of Enzymatic Analysis, Bergemeyer HU (ed.) Academic Press: New York, 783-785.
10. Lowry O, Rosebrough NJ, Farr AL, Randell RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 198: 266-275.
11. Mari M, Bai J, Cederbaum AI. 2002. Adenovirus-mediated over expression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP 2E1. J Pharm Exp Ther 301: 111-118.
12. Micu AL, Miksys S, Sellers E, Koop DR, Tyndale RF. 2003. Rat hepatic CYP 2E1 is induced by very low nicotine doses: An investigation of induction, time course, dose response, and mechanism. J Pharm Exp Ther 306: 941-947.
13. O'Brien PJ, Rahimtula AD. 1978. A peroxidase assay for cytochrome P-450. In Methods in Enzymology, Fleischer S, Packer L (eds). vol LII. Academic Press: New York, 407-412.
14. Sivarajan VV, Balachandran I. 1994. Ayurvedic Drugs and Their Plant Sources. Oxford & IBH Publication: New Delhi, 28-29.
15. Summanen JO. 1999. A Chemical and Ethnopharmacological Study on Phyllanthus emblica (Euphorbiaceae). Academic Dissertation, Faculty of Science of the University of Helsinki, University of Helsinki.
16. Tasduq SA, Singh K, Sethi S, et al. 2003. Hepatoprotective and antioxidant profile of HP-1, a polyherbal phytomedicine. Human Exp Toxicol 22: 639-645.
17. Turkdogan MK, Ozbek H, Yener Z, Tuncer I, Ceyloan E. 2003. The role of Urtica dioica and Nigella sativa in the prevention of carbon tetrachloride-induced hepatotoxicity in rats. Phytother Res 17: 942-946.
18. Unander DW, Webster GL, Blumberg BS. 1990. Records of usage or assays in Phyllanthus (Euphorbiaceae) I. Sub-genera Isocladus, Kirginelia, Cicca and Emblica. J Ethnopharmacol 30: 133-164.
19. Wong WM, Wu PC, Yuen MF, et al. 2000. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 31: 201-206.